Bluesky Facebook Reddit Email

Cascade-responsive nanobomb for anti-tumor synergistic therapies

10.20.21 | Science China Press

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.


Reactive oxygen species (ROS) can act as signal carriers during the evolution of malignant tumors. At the appropriate concentration, ROS mediate signal transduction and cell growth. However, ROS are a double-edged sword, as excessive ROS can oxidize proteins, damage the DNA structure, and induce cell apoptosis. Moreover, ROS can induce inflammation at the tumor site, which further improves tumor immunogenicity. Therefore, increasing the content of ROS in tumor sites has become an effective method for cancer therapy. At present, the ways to generate ROS through external stimulations, such as photodynamic reaction, sonodynamic reaction, and radiation sensitization, are greatly limited by the penetration depth of the laser, irradiation range of external excitation, and safety concerns of the radiation.

In response to these problems, chemodynamic therapy has been developed, which has received widespread attention. Chemodynamic therapy uses excess H 2 O 2 in the tumor microenvironment without external energy stimulation to generate ROS through the Fenton reaction. However, the current therapeutic effect of chemodynamic therapy is not satisfactory, because the initiation of an efficient Fenton reaction requires harsh acidic conditions and excess H 2 O 2 . In addition to exogenous ROS production strategies, increasing the generation of endogenous ROS to inhibit tumor growth is another promising approach. It is well known that inhibiting the mitochondrial electron transport chain can enhance the generation of ROS. However, treating cancer only by increasing endogenous ROS is unsatisfactory, as it is difficult to effectively inhibit tumor growth with a low amount of produced endogenous ROS. Therefore, developing strategies for the selective generation of sufficient ROS without external energy stimulation under mild in vivo conditions remains a huge challenge in the field of cancer therapy.

In a new research article published in the Beijing-based National Science Review , scientists at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China , designed a cascade-responsive ROS generation device with domino effect and without external stimulation for the specific generation of multiple severe ROS storms at the tumor site. Co-authors Yang Liu, Yinghui Wang, Shuyan Song and Hongjie Zhang find that the simple introduction of the prepared ZnO 2 @Ce6/CaP@CPPO/BSA nanobomb into the tumor would cause a “domino effect”, which could trigger the production of multiple ROS storms and Ca 2+ overload, as well as effectively activate the systemic immune response while inhibiting the growth of primary tumors. Moreover, tumor metastasis can be effectively prevented by adjuvant treatment with anti-CTLA4 checkpoint blockers.

###

This research received funding from the National Natural Science Foundation of China, the Strategic Priority Research Program of the Chinese Academy of Sciences, and the Youth Innovation Promotion Association of Chinese Academy of Sciences.

See the article:

Yang Liu, Yinghui Wang, Shuyan Song, and Hongjie Zhang

Cascade-responsive nanobomb with domino effect for anti-tumor synergistic therapies

National Science Review , 2021, nwab139, https://doi.org/10.1093/nsr/nwab139

National Science Review

10.1093/nsr/nwab139

Keywords

Article Information

Contact Information

Bei Yan
Science China Press
yanbei@scichina.org

How to Cite This Article

APA:
Science China Press. (2021, October 20). Cascade-responsive nanobomb for anti-tumor synergistic therapies. Brightsurf News. https://www.brightsurf.com/news/1477XMJ1/cascade-responsive-nanobomb-for-anti-tumor-synergistic-therapies.html
MLA:
"Cascade-responsive nanobomb for anti-tumor synergistic therapies." Brightsurf News, Oct. 20 2021, https://www.brightsurf.com/news/1477XMJ1/cascade-responsive-nanobomb-for-anti-tumor-synergistic-therapies.html.